(Q33338040)

English

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M J Edelman

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D R Gandara

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D H Lau

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Lara

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

I J Lauder

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Tracy

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

146-152

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010701%2992%3A1%3C146%3A%3AAID-CNCR1302%3E3.0.CO%3B2-N

21 January 2018

Identifiers

10.1002/1097-0142(20010701)92:1<146::AID-CNCR1302>3.0.CO;2-N

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

release_hqbgtraz4jh43duglb6wujwwqu

1 reference

https://api.fatcat.wiki/v0/release/hqbgtraz4jh43duglb6wujwwqu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33338040&oldid=1840578224"